| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $194.6M | -33.5% |
| Cost of Revenue | $74.1M | -12.6% |
| R&D Expense | $63.1M | -51.1% |
| SG&A Expense | $100.2M | -27.7% |
| Operating Income | -$46.3M | +41.5% |
| Pre-tax Income | -$51.9M | +43.9% |
| Net Income | -$51.9M | +43.9% |
| EPS (Basic) | -$0.28 | +45.1% |
| EPS (Diluted) | -$0.28 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $42.9M | -52.6% |
| Accounts Receivable | $39.3M | +0.3% |
| Inventory | $15.7M | -27.9% |
| Current Assets | $118.1M | -36.1% |
| Total Assets | $241.7M | -31.3% |
| Current Liabilities | $99.9M | -19.9% |
| Long-term Debt | $34.7M | -47.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$23.4M | +68.0% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | $0 | +100.0% |
| Financing Cash Flow | -$25.2M | -272.7% |
| Free Cash Flow | -$23.4M | +68.1% |
| +45.1% |
| Total Liabilities |
| $272.3M |
| -20.5% |
| Stockholders' Equity | -$30.6M | -427.4% |